press
Investor Kit
News Releases
NeoChord receives CE marking for DS1000 mitral valve repair device and plans first enrollments in TACT Registry for Q1 2013.
January 3, 2013
NeoChord obtains exclusive rights to state-of-the-art, award-winning "augmented reality" imaging technology
October 2, 2012
NeoChord completes enrollment for "TACT" clinical trial
September 10, 2012
"NeoChord closes on $5.1 million in Series B funding."
August, 2011
"Hopen nabs 25M for Second Fund."
August, 2011
"Case report of a patient in the TACT trial at Heart Centre, Leipzig University published."
Fall, 2011
"NeoChord Enrolls First Patient in European Clinical Trial"
October 28, 2009
"Minnetonka Firm to Test New Heart Valve Repair..."
July 14, 2009
"NeoChord Raises At Least $2.8 million for Mitral Valve Repair Technology"
July 6, 2009
"Start-up raises $1.2M for heart 'strings'"
October 17, 2008
"Clarian Invests in Minnesota Technology Company"
October 7, 2008
"Mayo Clinic + Neochord"
November 12, 2007
Events
Look for NeoChord presentations at the upcoming AATS Annual Meeting May 4th - 8th, 2013 in Minneapolis, Minnesota.